Anebulo Pharmaceuticals, Inc.
(NASDAQ: ANEB)
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.
2.370
+0.040
(+1.72%)
Range
2.261 - 2.370
(4.82%)
Open
2.370
Previous Close
2.330
Bid Price
-
Bid Volume
8
Ask Price
2.550
Ask Volume
18
Volume
936
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
